Advertisement
Advertisement
NEO
NeoGenomics, Inc.
18.94
USDSponsored
+0.05
+0.26%
Sep 16, 15:59 UTC -4
Closed
After-Market
18.84
-0.11
-0.55%
NEO Earnings Reports
Positive Surprise Ratio
NEO beat 38 of 43 last estimates.
88%
Next Report
Date of Next Report
Oct 26, 2026
Estimate for Q3 26 (Revenue/ EPS)
$207.94M
/$0.05
Implied change from Q2 26 (Revenue/ EPS)
+3.12%
/--
Implied change from Q3 25 (Revenue/ EPS)
+10.73%
/+66.67%
NeoGenomics, Inc. earnings per share and revenue
On Jul 28, 2026, NEO reported earnings of 0.05 USD per share (EPS) for Q2 26, beating the estimate of 0.03 USD, resulting in a 51.06% surprise. Revenue reached 201.66 million, compared to an expected 198.97 million, with a 1.35% difference. The market reacted with a +13.96% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 14 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 207.94 million USD, implying an increase of 0.00% EPS, and increase of 3.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were NeoGenomics, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, NeoGenomics, Inc. reported EPS of $0.05, beating estimates by 51.06%, and revenue of $201.66M, 1.35% above expectations.
How did the market react to NeoGenomics, Inc.'s Q2 2026 earnings?
The stock price moved up 13.96%, changed from $13.40 before the earnings release to $15.27 the day after.
When is NeoGenomics, Inc. expected to report next?
The next earning report is scheduled for Oct 26, 2026.
What are the forecasts for NeoGenomics, Inc.'s next earnings report?
Based on 14
analysts, NeoGenomics, Inc. is expected to report EPS of $0.05 and revenue of $207.94M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.